Supplementary Materials from Therapeutic Potential of HSP90 Inhibition for Neurofibromatosis Type 2Karo Tanaka, Marco Giovannini(Inserm)UnknownMarch 31, 202310.1158/1078-0432.22450142.v1Cited by 0SaveCiteExport RISWatch citationsRelated PapersmTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma|Neuro-Oncology|2014|78Supplementary Materials from Therapeutic Potential of HSP90 Inhibition for Neurofibromatosis Type 2|Unknown|2023|0